Invesco Ltd. Has $415.43 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

Key Points

• Invesco Ltd. has reduced its stake in HCA Healthcare, Inc. by 11.4%, selling 154,302 shares and now owning approximately 1,202,215 shares valued at $415.4 million.
• Several institutional investors have increased their holdings in HCA, with J.W. Cole Advisors Inc. raising its stake by 145.3% during the same period.
• The latest earnings report for HCA Healthcare showed an EPS of $6.84, exceeding estimates by $0.64, and revenue of $18.61 billion, which was up 6.4% year-over-year.

Invesco Ltd. cut its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 11.4% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,202,215 shares of the company's stock after selling 154,302 shares during the quarter. Invesco Ltd. owned approximately 0.50% of HCA Healthcare worth $415,425,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Covestor Ltd increased its stake in shares of HCA Healthcare by 21.4% in the first quarter. Covestor Ltd now owns 522 shares of the company's stock valued at $180,000 after buying an additional 92 shares in the last quarter. Frank Rimerman Advisors LLC increased its stake in shares of HCA Healthcare by 4.0% in the first quarter. Frank Rimerman Advisors LLC now owns 6,899 shares of the company's stock valued at $2,384,000 after buying an additional 267 shares in the last quarter. Koss Olinger Consulting LLC acquired a new stake in shares of HCA Healthcare in the first quarter valued at $326,000. Townsquare Capital LLC increased its stake in shares of HCA Healthcare by 24.2% in the first quarter. Townsquare Capital LLC now owns 3,117 shares of the company's stock valued at $1,077,000 after buying an additional 607 shares in the last quarter. Finally, Zions Bancorporation National Association UT acquired a new stake in shares of HCA Healthcare in the first quarter valued at $98,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Up 0.0%

HCA Healthcare stock traded up $0.03 during midday trading on Wednesday, reaching $390.34. The stock had a trading volume of 1,416,060 shares, compared to its average volume of 1,586,285. The firm's fifty day simple moving average is $369.89 and its 200-day simple moving average is $350.30. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The stock has a market capitalization of $91.34 billion, a P/E ratio of 16.41, a price-to-earnings-growth ratio of 1.23 and a beta of 1.39. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping the consensus estimate of $6.20 by $0.64. The firm had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%. The business's quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $5.50 EPS. As a group, analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be given a dividend of $0.72 per share. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. HCA Healthcare's payout ratio is 12.11%.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on HCA. Stephens upgraded HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Royal Bank Of Canada reduced their target price on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a report on Monday, July 28th. Morgan Stanley reduced their target price on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a report on Monday, July 28th. Wells Fargo & Company upgraded HCA Healthcare from an "underweight" rating to an "equal weight" rating and raised their target price for the stock from $320.00 to $385.00 in a report on Thursday, May 29th. Finally, Barclays cut their price objective on HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating on the stock in a report on Monday, July 28th. Nine analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $395.69.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.